Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-16T16:08:51.704Z Has data issue: false hasContentIssue false

Effects of 5-Hydroxytryptophan on Schizophrenia

Published online by Cambridge University Press:  08 February 2018

J. C. Brengelmann
Affiliation:
Institute of Psychiatry, Maudsley Hospital, London, S.E.5
C. M. B. Pare
Affiliation:
Bethlem Royal and the Maudsley Hospital, London, S.E.5
M. Sandler
Affiliation:
Royal Free Hospital, London, W.C.1
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

The present investigation represents a logical continuation of a previous experiment where it was shown that the injection of 5-hydroxytryptophan (5HTP) alleviates the psychological effects of lysergic acid diethylamide (LSD-25) (Brengelmann, Pare and Sandler, 1958). LSD is of interest in psychiatry because the psychotomimetic effects of the drug bear a resemblance to schizophrenia clinically, in psychological tests and, according to Hoagland, Rinkel and Hyde (1955), in their abnormal excretion of urinary phosphate. The possibility presents itself that, in some cases of schizophrenia, the functional abnormality is similar to that produced by LSD.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1959 
Submit a response

eLetters

No eLetters have been published for this article.